AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Cencora (COR)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

240.97

-1.66 (-0.68%)

At close: Feb 18, 2025, 3:59 PM

241.40

0.18%

After-hours: Feb 18, 2025, 07:35 PM EST

undefined% (undefined)

Bid	238.09
Market Cap	46.73B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	7.06
PE Ratio (ttm)	34.13
Forward PE	n/a
Analyst	Buy

Ask	243.2
Volume	866,229
Avg. Volume (20D)	1,315,811
Open	240.86
Previous Close	242.63
Day's Range	237.77 - 243.33
52-Week Range	214.77 - 262.26
Beta	undefined

About COR

Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pha...

[Show more]

Industry Medical - Distribution

Sector Healthcare

IPO Date Apr 4, 1995

Employees 46,000

Stock Exchange NYSE

Ticker Symbol COR

Website https://www.amerisourcebergen.com

Full Company Profile

Analyst Forecast

According to 9 analyst ratings, the average rating for COR stock is "Buy." The 12-month stock price forecast is $285, which is an increase of 18.27% from the latest price.

Buy 77.78%

Hold 22.22%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Cencora is scheduled to release its earnings on Apr 30, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

6 months ago

+2.96%

Cencora shares are trading higher after the compan... Unlock content with Pro Subscription

7 months ago

-3.93%

Cencora shares are trading lower after Walgreens lowered its outlook and announced store closure.

News

5 days ago · zacks.com

3 GARP Stocks That Investors Can Scoop Up for Maximum Returns

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. AXP, COR and TPX hold promise.

1 week ago · forbes.com

Walgreens Sells Another Stake In Distributor Cencora For $300 Million

Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said Thursday nig...

1 week ago · businesswire.com

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of ap...

1 week ago · businesswire.com

Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) has agreed to the early settlement of certain prepaid variable share forward transactions it had previously entered into ...

1 week ago · zacks.com

COR Stock Gains on Q1 Earnings & Revenue Beat & Upbeat '25 Outlook

COR's first-quarter fiscal 2025 results showcase a strong segmental performance. The company's sales and earnings guidance for fiscal 2025 looks encouraging.

1 week ago · seekingalpha.com

Cencora (COR) Q1 2025 Earnings Call Transcript

Cencora Inc. (NYSE:COR ) Q1 2025 Earnings Conference Call February 5, 2025 8:30 AM ET Company Participants Robert Mauch - President, Chief Executive Officer James Cleary - Executive Vice President, Ch...

1 week ago · zacks.com

Here's What Key Metrics Tell Us About Cencora (COR) Q1 Earnings

The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estima...

1 week ago · zacks.com

Cencora (COR) Surpasses Q1 Earnings and Revenue Estimates

Cencora (COR) came out with quarterly earnings of $3.73 per share, beating the Zacks Consensus Estimate of $3.50 per share. This compares to earnings of $3.28 per share a year ago.

2 weeks ago · reuters.com

Cencora raises 2025 profit forecast on specialty drug demand

Drug distributor Cencora raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines.

2 weeks ago · businesswire.com

Cencora Reports Fiscal 2025 First Quarter Results

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year to $81.5 billio...

Load More News